Clodia Osipo Selected Research

MRK 003

6/2011

NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clodia Osipo Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 06/2022 - 11/2003
27	Neoplasms (Cancer) 06/2022 - 11/2003
3	Osteoporosis 04/2006 - 11/2003
2	Tics (Tic) 01/2020 - 10/2019
1	Genomic Instability 10/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Triple Negative Breast Neoplasms 06/2011
1	Neoplasm Metastasis (Metastasis) 06/2010
1	Lobular Carcinoma 07/2008
1	Hypersensitivity (Allergy) 04/2006
1	Endometrial Neoplasms (Endometrial Cancer) 09/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2003
9	Estrogen ReceptorsIBA 01/2020 - 02/2005
9	Tamoxifen FDA LinkGeneric 07/2008 - 11/2003
7	Trastuzumab (Herceptin)FDA Link 01/2018 - 09/2005
7	Fulvestrant (Faslodex)FDA Link 02/2007 - 11/2003
7	Estrogens (Estrogen)FDA Link 02/2007 - 11/2003
6	Estradiol (Delestrogen)FDA LinkGeneric 10/2019 - 11/2003
6	Estrogen Receptor alphaIBA 07/2008 - 11/2003
5	Messenger RNA (mRNA)IBA 01/2018 - 11/2003
5	Phosphotransferases (Kinase)IBA 10/2017 - 09/2005
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020 - 07/2008
4	ErbB Receptors (EGF Receptor)IBA 06/2016 - 04/2006
4	Biomarkers (Surrogate Marker)IBA 04/2013 - 07/2008
4	Estrogen Receptor Modulators (Antiestrogen)IBA 07/2008 - 09/2004
4	Raloxifene Hydrochloride (Evista)FDA Link 04/2006 - 11/2003
3	Lapatinib (GW572016)FDA Link 01/2018 - 08/2015
3	Jagged-1 ProteinIBA 01/2018 - 07/2008
3	Notch ReceptorsIBA 01/2014 - 07/2008
3	Epidermal Growth Factor (EGF)IBA 01/2013 - 12/2009
3	Selective Estrogen Receptor Modulators (SERM)IBA 04/2006 - 11/2003
3	Aromatase InhibitorsIBA 12/2005 - 09/2004
2	Phytoestrogens (Phytoestrogen)IBA 06/2022 - 01/2020
2	human ERBB2 proteinIBA 01/2020 - 08/2015
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 01/2014
2	Tyrosine (L-Tyrosine)FDA Link 10/2017 - 02/2007
2	NF-kappa B (NF-kB)IBA 01/2008 - 11/2003
2	Glycogen Synthase (Synthase I)IBA 02/2007 - 04/2006
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2007 - 09/2005
2	Gefitinib (Iressa)FDA Link 11/2006 - 04/2006
1	naringeninIBA 01/2020
1	ResveratrolIBA 01/2020
1	QuercetinIBA 01/2020
1	GenisteinIBA 01/2020
1	ApigeninIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Excipients (Suspending Agents)IBA 10/2019
1	Potassium Channels (Potassium Channel)IBA 01/2018
1	PotassiumIBA 01/2018
1	1,3- bis(2- hydroxy- 5- trifluoromethylphenyl)ureaIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	BRCA1 ProteinIBA 10/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Deubiquitinating EnzymesIBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Mitogen-Activated Protein Kinase Kinase Kinase 11IBA 08/2015
1	Mitogen-Activated Protein KinasesIBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	Tumor Biomarkers (Tumor Markers)IBA 04/2013
1	LigandsIBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Formaldehyde (Formol)FDA Link 01/2012
1	Proto-Oncogene Proteins c-etsIBA 06/2011
1	Small Interfering RNA (siRNA)IBA 06/2011
1	MRK 003IBA 06/2011
1	Notch4 ReceptorIBA 06/2011
1	tyrosine receptor (receptor, tyrosine)IBA 12/2009
1	Gamma Secretase Inhibitors and ModulatorsIBA 01/2009
1	Cathepsin DIBA 02/2007
1	pertuzumabIBA 02/2007
1	Growth Factor ReceptorsIBA 04/2006
1	Nuclear Receptor Coactivator 3IBA 04/2006
1	Cyclin D1IBA 04/2006
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2006
1	Caspase 7IBA 04/2006
1	Angiogenesis InhibitorsIBA 12/2005
1	Aromatase (CYP19)IBA 12/2005
1	Insulin-Like PeptidesIBA 09/2005
1	Insulin Receptor Substrate ProteinsIBA 09/2005
1	Growth InhibitorsIBA 09/2005
1	Anastrozole (Arimidex)FDA LinkGeneric 02/2005
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2004
1	Fas Ligand Protein (Fas Ligand)IBA 11/2003
1	Death Domain ReceptorsIBA 11/2003

Therapy/Procedure

19	Therapeutics 06/2022 - 09/2004
3	Drug Therapy (Chemotherapy) 01/2020 - 09/2004
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2022
1	Radiotherapy 01/2018
1	Molecular Targeted Therapy 01/2014
1	Transplantation 02/2005